Dose-response relationships for spironolactone at steady state

Area of Science:

• Pharmacology
• Nephrology
• Endocrinology

Background:

• Aldosterone antagonists are crucial in managing conditions like heart failure and hypertension.
• Spironolactone is a widely used potassium-sparing diuretic.
• Understanding its dose-response relationship and efficacy is vital for clinical application.

Purpose of the Study:

• To investigate the dose-dependent effects of spironolactone on electrolyte balance.
• To evaluate the utility of the fludrocortisone challenge model in assessing spironolactone's activity.
• To determine the reliability of the urine sodium-to-potassium ratio as an indicator of antimineralocorticoid effects.

Main Methods:

• 11 healthy subjects received varying daily doses of spironolactone (25-200 mg) at steady state.
• A fludrocortisone challenge was administered to assess renal responses.
• Overnight urine electrolytes and plasma potassium levels were measured.

Main Results:

• A significant log dose-response relationship was observed for sodium excretion (P < 0.001).
• A similar dose-response was found for the urine sodium/potassium ratio (P < 0.001).
• Little evidence of dose-related effects on potassium excretion or plasma potassium was detected.

Conclusions:

• Spironolactone exhibits dose-dependent effects on sodium excretion but not significantly on potassium balance in this model.
• The fludrocortisone challenge model has limitations for evaluating potassium-sparing properties of aldosterone antagonists at steady state.
• The urine sodium/potassium ratio may not be a comprehensive index of renal antimineralocorticoid activity.